DataSuds

Metrics

126,756 Downloads

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

License: Custom Terms

731 to 740 of 8,481 Results

Data_Use_Agreement_Template.pdf May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project) Adobe PDF - 60.2 KB - MD5: c315b2d8e14230adeed9a06ada7b154c Documentation Data use agreement template. The form must be downloaded, completed and returned to the authors of the dataset and data@ird.fr before access to the data files is granted.
ReadMe_KCEDO2.txt May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project) Plain Text - 3.2 KB - MD5: 50d40660aca5bc2534f84297b28beb6c Documentation Contains citation, description and conditions of use of dataset data
WHODAS_Loa_Congo_PlosNTD_Data.tab May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project) Tabular Data - 279.1 KB - 41 Variables, 991 Observations - UNF:6:PqyFALRq3bZu/zOietLriw== Données Data from WHODAS 2.0 12-item and EQ-5D-5L questionnaires
WHODAS_Loa_Congo_PlosNTD_Dictionnary_Data.tab May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project) Tabular Data - 2.5 KB - 12 Variables, 36 Observations - UNF:6:ui7L6W5QiM700BJWaUsesg== Documentation Data dictionnary
Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial May 23, 2025 - UMI TransVIHMI Cédric B. Chesnais; Marlhand C. Hemilembolo; Bachiratou A. Sahm; Florentin Toutin; Ericson Djeutassong; Nadia Nga-Elomo; Benjamin Cuer; Mas A. Ntsiba-N’goulou; Miveck Pakat; Sébastien D. S. Pion; François Missamou; Michel Boussinesq; Jérémy T Campillo, 2025, "Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial", https://doi.org/10.23708/TTJXSF, DataSuds, V1, UNF:6:QDTu5z2Y7xIeanRSu3mpUw== [fileUNF] Background. Individuals with high Loa loa microfilarial densities (MFD) risk serious adverse events (SAEs) following ivermectin treatment. A single dose of levamisole (LEV) induces a temporary, progressive MFD decrease. We assessed the safety and efficacy of 3- and 5-day LEV (LEV...
CRF.pdf May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Adobe PDF - 879.3 KB - MD5: de113c80381c87ac2465ec7e903e2e56 Documentation Case report form (PDF, 19 pages).
Data.tab May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Tabular Data - 18.8 KB - 1 Variables, 546 Observations - UNF:6:QDTu5z2Y7xIeanRSu3mpUw== Données Main dataset, pseudoanonymized (text UTF-8, tab-separated values).
LEV-Loa-README.txt May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Plain Text - 3.1 KB - MD5: 17ef164af6d4c1a6c7466501e9c45a83 Documentation Dataset citation, dictionnary and description.
Protocole (french) May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Adobe PDF - 978.7 KB - MD5: abcbc134d5a6b7e9bd11ac8cfa781362 Documentation Study protocol (PDF, 41 pages).
Sierem_Isohyetes40_69.dbf May 13, 2025 - Isohyets of annual rainfall map of Africa dBASE Table for ESRI Shapefile - 7.7 KB - MD5: 413568f000ee0a1fad3abc7b6ada091f Data isohyets of the annual Rainfall Map of Africa

Data_Use_Agreement_Template.pdf

May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)

Adobe PDF - 60.2 KB -

Documentation

Data use agreement template. The form must be downloaded, completed and returned to the authors of the dataset and data@ird.fr before access to the data files is granted.

ReadMe_KCEDO2.txt

Plain Text - 3.2 KB -

Documentation

Contains citation, description and conditions of use of dataset data

WHODAS_Loa_Congo_PlosNTD_Data.tab

Tabular Data - 279.1 KB - 41 Variables, 991 Observations -

Données

Data from WHODAS 2.0 12-item and EQ-5D-5L questionnaires

WHODAS_Loa_Congo_PlosNTD_Dictionnary_Data.tab

Tabular Data - 2.5 KB - 12 Variables, 36 Observations -

Documentation

Data dictionnary

Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

May 23, 2025 - UMI TransVIHMI

Cédric B. Chesnais; Marlhand C. Hemilembolo; Bachiratou A. Sahm; Florentin Toutin; Ericson Djeutassong; Nadia Nga-Elomo; Benjamin Cuer; Mas A. Ntsiba-N’goulou; Miveck Pakat; Sébastien D. S. Pion; François Missamou; Michel Boussinesq; Jérémy T Campillo, 2025, "Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial", https://doi.org/10.23708/TTJXSF, DataSuds, V1, UNF:6:QDTu5z2Y7xIeanRSu3mpUw== [fileUNF]

Background. Individuals with high Loa loa microfilarial densities (MFD) risk serious adverse events (SAEs) following ivermectin treatment. A single dose of levamisole (LEV) induces a temporary, progressive MFD decrease. We assessed the safety and efficacy of 3- and 5-day LEV (LEV...

CRF.pdf

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Adobe PDF - 879.3 KB -

Documentation

Case report form (PDF, 19 pages).

Data.tab

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Tabular Data - 18.8 KB - 1 Variables, 546 Observations -

Données

Main dataset, pseudoanonymized (text UTF-8, tab-separated values).

LEV-Loa-README.txt

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Plain Text - 3.1 KB -

Documentation

Dataset citation, dictionnary and description.

Protocole (french)

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Adobe PDF - 978.7 KB -

Documentation

Study protocol (PDF, 41 pages).

Sierem_Isohyetes40_69.dbf

May 13, 2025 - Isohyets of annual rainfall map of Africa

dBASE Table for ESRI Shapefile - 7.7 KB -

Data

isohyets of the annual Rainfall Map of Africa

Add Data

Share Dataverse

Link Dataverse

Reset Modifications